INR 147.8
(2.28%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 83.1 Million INR | -11.94% |
2022 | 397.11 Million INR | 6.33% |
2021 | 373.48 Million INR | 38.61% |
2020 | 269.44 Million INR | 41.03% |
2019 | 191.05 Million INR | 32.27% |
2018 | 144.44 Million INR | 1.75% |
2017 | 141.96 Million INR | -13.9% |
2016 | 164.88 Million INR | -11.18% |
2015 | 185.63 Million INR | -7.38% |
2014 | 200.43 Million INR | -14.16% |
2013 | 233.48 Million INR | 17.88% |
2012 | 198.06 Million INR | -7.98% |
2011 | 215.24 Million INR | 41.45% |
2010 | 152.17 Million INR | 389.53% |
2009 | 31.08 Million INR | 242.53% |
2008 | 9.07 Million INR | -10.03% |
2007 | 10.08 Million INR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 96.66 Million INR | 30.61% |
2024 Q2 | 114.38 Million INR | 18.33% |
2023 Q3 | 78.67 Million INR | -46.22% |
2023 Q1 | 142.91 Million INR | 270.91% |
2023 FY | 349.71 Million INR | -11.94% |
2023 Q2 | 146.28 Million INR | 2.36% |
2023 Q4 | 74.01 Million INR | -5.92% |
2022 Q3 | 157.32 Million INR | -9.96% |
2022 Q1 | 148.68 Million INR | 290.3% |
2022 FY | 397.11 Million INR | 6.33% |
2022 Q2 | 174.72 Million INR | 17.51% |
2022 Q4 | -83.62 Million INR | -153.15% |
2021 Q2 | 149.32 Million INR | -0.94% |
2021 Q1 | 150.74 Million INR | 92.5% |
2021 Q4 | -78.13 Million INR | -151.56% |
2021 FY | 373.48 Million INR | 38.61% |
2021 Q3 | 151.55 Million INR | 1.49% |
2020 FY | 269.44 Million INR | 41.03% |
2020 Q3 | 78.21 Million INR | 24.11% |
2020 Q2 | 63.02 Million INR | 26.3% |
2020 Q1 | 49.89 Million INR | 53.77% |
2020 Q4 | 78.3 Million INR | 0.12% |
2019 Q2 | 60.37 Million INR | 23.88% |
2019 FY | 191.05 Million INR | 32.27% |
2019 Q4 | 32.45 Million INR | -34.44% |
2019 Q3 | 49.49 Million INR | -18.02% |
2019 Q1 | 48.73 Million INR | 461.58% |
2018 Q1 | 46.41 Million INR | 3.59% |
2018 FY | 144.44 Million INR | 1.75% |
2018 Q4 | 8.67 Million INR | -80.37% |
2018 Q3 | 44.19 Million INR | -3.68% |
2018 Q2 | 45.88 Million INR | -1.13% |
2017 Q1 | 46.61 Million INR | -1.61% |
2017 Q4 | 44.8 Million INR | 13.87% |
2017 FY | 141.96 Million INR | -13.9% |
2017 Q3 | 39.34 Million INR | -2.87% |
2017 Q2 | 40.5 Million INR | -13.11% |
2016 Q1 | 47.03 Million INR | -18.36% |
2016 FY | 164.88 Million INR | -11.18% |
2016 Q4 | 47.38 Million INR | 8.79% |
2016 Q3 | 43.55 Million INR | -22.92% |
2016 Q2 | 56.5 Million INR | 20.13% |
2015 FY | 185.63 Million INR | -7.38% |
2015 Q1 | 54.25 Million INR | 13.31% |
2015 Q2 | 49.61 Million INR | -8.55% |
2015 Q3 | 43.55 Million INR | -12.23% |
2015 Q4 | 57.61 Million INR | 32.29% |
2014 Q4 | 47.88 Million INR | -5.16% |
2014 Q1 | 55.32 Million INR | 20.99% |
2014 FY | 200.43 Million INR | -14.16% |
2014 Q2 | 58.74 Million INR | 6.18% |
2014 Q3 | 50.49 Million INR | -14.04% |
2013 Q1 | 58.46 Million INR | -10.97% |
2013 Q4 | 45.72 Million INR | -4.81% |
2013 Q2 | 62.72 Million INR | 7.29% |
2013 FY | 233.48 Million INR | 17.88% |
2013 Q3 | 48.03 Million INR | -23.42% |
2012 Q3 | 49.47 Million INR | -0.55% |
2012 Q1 | 49.39 Million INR | 0.36% |
2012 FY | 198.06 Million INR | -7.98% |
2012 Q4 | 65.66 Million INR | 32.73% |
2012 Q2 | 49.74 Million INR | 0.71% |
2011 Q3 | 54.53 Million INR | 0.0% |
2011 FY | 215.24 Million INR | 41.45% |
2011 Q4 | 49.22 Million INR | -9.74% |
2010 FY | 152.17 Million INR | 389.53% |
2009 FY | 31.08 Million INR | 242.53% |
2008 FY | 9.07 Million INR | -10.03% |
2007 FY | 10.08 Million INR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
ANG Lifesciences India Limited | 219.92 Million INR | 62.213% |
Add-Shop E-Retail Limited | 146.52 Million INR | 43.284% |
Bacil Pharma Limited | 1.87 Million INR | -4333.656% |
BDH Industries Limited | 57.03 Million INR | -45.715% |
Beryl Drugs Limited | 93.77 Million INR | 11.376% |
Cian Healthcare Limited | 59.19 Million INR | -40.381% |
Chemo Pharma Laboratories Limited | 1.94 Million INR | -4168.31% |
Concord Drugs Limited | 91.83 Million INR | 9.504% |
Deccan Health Care Limited | 36.24 Million INR | -129.303% |
DECIPHER LABS LIMITED | 277.6 Million INR | 70.063% |
Gujarat Terce Laboratories Limited | 132.41 Million INR | 37.242% |
Gujarat Themis Biosyn Limited | 156.84 Million INR | 47.016% |
Hindustan Bio Sciences Limited | 2.6 Million INR | -3085.963% |
Jenburkt Pharmaceuticals Limited | 437.2 Million INR | 80.992% |
Ishita Drugs and Industries Limited | 16.46 Million INR | -404.67% |
Kwality Pharmaceuticals Limited | 248.93 Million INR | 66.616% |
Panchsheel Organics Limited | 68.15 Million INR | -21.927% |
KIMIA BIOSCIENCES LIMITED | 149.52 Million INR | 44.42% |
Parnax Lab Limited | 80.59 Million INR | -3.117% |
Medi-Caps Limited | 93.11 Million INR | 10.754% |
MedPlus Health Services Limited | 2.42 Billion INR | 96.572% |
Phaarmasia Limited | 50.52 Million INR | -64.478% |
Parmax Pharma Limited | 99.31 Million INR | 16.325% |
Patidar Buildcon Limited | 1.81 Million INR | -4488.846% |
Sanjivani Paranteral Limited. | 208.87 Million INR | 60.214% |
SHAMROCK INDUSTRIAL CO.LTD. | 1.52 Million INR | -5353.018% |
Trident Lifeline Limited | 46.87 Million INR | -77.304% |
Tyche Industries Limited | 182.04 Million INR | 54.349% |
Vivanza Biosciences Limited | 4.55 Million INR | -1724.457% |
PRAVEG LIMITED | 77.18 Million INR | -7.673% |
Smruthi Organics Limited | 261.73 Million INR | 68.249% |
Source Natural Foods and Herbal Supplements Limited | 31.85 Million INR | -160.866% |
SUDARSHAN PHARMA INDUSTRIES LI | 146.09 Million INR | 43.115% |
Sastasundar Ventures Limited | 846.78 Million INR | 90.186% |
Transchem Limited | 8.47 Million INR | -880.81% |
Trinity League India Limited | -1.08 Million INR | 7752.302% |
Vikram Thermo (India) Limited | 104.27 Million INR | 20.304% |
Vista Pharmaceuticals Limited | 20.16 Million INR | -312.1% |
Sunil Healthcare Limited | 438.1 Million INR | 81.031% |
Syschem (India) Limited | 64.13 Million INR | -29.583% |
Zenith Healthcare Limited | 45.97 Million INR | -80.747% |
Zenlabs Ethica Limited | 57.89 Million INR | -43.543% |
Mercury Laboratories Limited | 217.24 Million INR | 61.746% |
SHELTER PHARMA LIMITED | 12.3 Million INR | -575.615% |
Vasundhara Rasayans Limited | 145.5 Million INR | 42.887% |
Bharat Immunologicals & Biologicals Corporation Limited | 184.08 Million INR | 54.855% |
Roopa Industries Limited | 24.63 Million INR | -237.341% |
PANJON LTD. | 33.77 Million INR | -146.023% |
Pharmaids Pharmaceuticals Limited | 76.49 Million INR | -8.641% |
TIAAN CONSUMER LIMITED | 107 Thousand INR | -77567.29% |
Anuh Pharma Limited | 263.04 Million INR | 68.407% |
Crestchem Limited | 50.8 Million INR | -63.582% |
Emmessar Biotech & Nutrition Limited | 4.32 Million INR | -1822.814% |
Sandu Pharmaceuticals Limited | 212.9 Million INR | 60.966% |
Fredun Pharmaceuticals Limited | 360.45 Million INR | 76.945% |
Trimurthi Limited | 4.81 Million INR | -1627.375% |
Shukra Pharmaceuticals Limited | 83.05 Million INR | -0.061% |
Norris Medicines Limited | 18.2 Million INR | -356.486% |
Veerhealth Care Limited | 15.38 Million INR | -440.268% |
Lactose (India) Limited | 111.66 Million INR | 25.575% |
OXYGENTA PHARMACEUTICAL LIMITE | 23.78 Million INR | -249.47% |
Ambalal Sarabhai Enterprises Limited | 280.83 Million INR | 70.408% |
Gennex Laboratories Limited | 130.37 Million INR | 36.259% |
Denis Chem Lab Limited | 453.36 Million INR | 81.67% |
Colinz Laboratories Limited | 31.19 Million INR | -166.376% |
Godavari Drugs Limited | 359.01 Million INR | 76.852% |
Zenotech Laboratories Limited | 94.82 Million INR | 12.358% |
Shree Ganesh Remedies Limited | 104.13 Million INR | 20.196% |
Bharat Parenterals Limited | 255.97 Million INR | 67.535% |
Coral Laboratories Limited | 189.75 Million INR | 56.206% |
Evoq Remedies Limited | 4.51 Million INR | -1739.805% |
Kerala Ayurveda Limited | 399.64 Million INR | 79.206% |
KOBO BIOTECH LIMITED | 2.48 Million INR | -3250.968% |
Natural Capsules Limited | 444.7 Million INR | 81.312% |
Auro Laboratories Limited | 157.37 Million INR | 47.194% |